Thomas H. Lee Advisors, LLC is of Syneos Health, Inc.. Currently has a direct ownership of 0 shares of SYNH, which is worth approximately $0. The most recent transaction as insider was on Jun 07, 2021, when has been sold 1,179 shares (Class A Common Stock) at a price of $81.2 per share, resulting in proceeds of $95,735. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

THOMAS H. LEE ADVISORS, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2021
SELL
Open market or private sale
$95,735 $81.2 p/Share
1,179 Reduced 100.0%
0 Class A Common Stock
Jun 07 2021
SELL
Open market or private sale
$95,735 $81.2 p/Share
1,179 Reduced 100.0%
0 Class A Common Stock
May 12 2021
SELL
Open market or private sale
$7,213 $81.04 p/Share
89 Reduced 21.39%
327 Class A Common Stock
May 12 2021
SELL
Open market or private sale
$7,213 $81.04 p/Share
89 Reduced 21.39%
327 Class A Common Stock
May 12 2021
BUY
Grant, award, or other acquisition
-
4,728 Added 26.09%
13,392 Class A Common Stock
May 12 2021
BUY
Grant, award, or other acquisition
-
4,728 Added 26.09%
13,392 Class A Common Stock
May 06 2021
SELL
Open market or private sale
$64,346 $81.04 p/Share
794 Reduced 69.28%
352 Class A Common Stock
May 06 2021
SELL
Open market or private sale
$64,346 $81.04 p/Share
794 Reduced 69.28%
352 Class A Common Stock
Mar 03 2021
SELL
Open market or private sale
$69,349 $74.17 p/Share
935 Reduced 62.04%
572 Class A Common Stock
Mar 03 2021
SELL
Open market or private sale
$69,349 $74.17 p/Share
935 Reduced 62.04%
572 Class A Common Stock
Dec 03 2020
SELL
Open market or private sale
$38,423 $61.28 p/Share
627 Reduced 43.0%
831 Class A Common Stock
Dec 03 2020
SELL
Open market or private sale
$38,423 $61.28 p/Share
627 Reduced 43.0%
831 Class A Common Stock
Sep 17 2020
SELL
Open market or private sale
$43,378 $59.26 p/Share
732 Reduced 42.14%
1,005 Class A Common Stock
Sep 17 2020
SELL
Open market or private sale
$43,378 $59.26 p/Share
732 Reduced 42.14%
1,005 Class A Common Stock
May 27 2020
BUY
Grant, award, or other acquisition
-
5,606 Added 33.7%
11,028 Class A Common Stock
May 27 2020
BUY
Grant, award, or other acquisition
-
5,606 Added 33.7%
11,028 Class A Common Stock
May 24 2019
BUY
Grant, award, or other acquisition
-
8,244 Added 50.06%
8,225 Class A Common Stock
May 24 2019
BUY
Grant, award, or other acquisition
-
8,244 Added 50.06%
8,225 Class A Common Stock
May 24 2018
BUY
Grant, award, or other acquisition
-
8,206 Added 56.64%
6,281 Class A Common Stock
May 24 2018
BUY
Grant, award, or other acquisition
-
8,206 Added 56.64%
6,281 Class A Common Stock
Aug 01 2017
BUY
Grant, award, or other acquisition
-
4,356 Added 66.67%
2,178 Class A Common Stock
Aug 01 2017
BUY
Grant, award, or other acquisition
-
4,356 Added 66.67%
2,178 Class A Common Stock

Also insider at

UMPQ
UMPQUA HOLDINGS CORP Financial Services
PRTY
Party City Holdco Inc. Consumer Cyclical
CDAY
Ceridian HCM Holding Inc. Technology
IHRT
iHeartMedia, Inc. Communication Services
DNB
Dun & Bradstreet Holdings, Inc. Financial Services
THL

Thomas H. Lee Advisors, LLC

Boston, MA

Track Institutional and Insider Activities on SYNH

Follow Syneos Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYNH shares.

Notify only if

Insider Trading

Get notified when an Syneos Health, Inc. insider buys or sells SYNH shares.

Notify only if

News

Receive news related to Syneos Health, Inc.

Track Activities on SYNH